175 related articles for article (PubMed ID: 21078555)
1. Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques.
Noha SM; Atanasov AG; Schuster D; Markt P; Fakhrudin N; Heiss EH; Schrammel O; Rollinger JM; Stuppner H; Dirsch VM; Wolber G
Bioorg Med Chem Lett; 2011 Jan; 21(1):577-83. PubMed ID: 21078555
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening.
Al-Sha'er MA; Almazari IS; Taha MO
J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28008665
[TBL] [Abstract][Full Text] [Related]
3. IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.
Nagarajan S; Choo H; Cho YS; Oh KS; Lee BH; Shin KJ; Pae AN
Bioorg Med Chem; 2010 Jun; 18(11):3951-60. PubMed ID: 20488717
[TBL] [Abstract][Full Text] [Related]
4. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
[TBL] [Abstract][Full Text] [Related]
5. Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.
Elkamhawy A; Youn Kim N; Hassan AHE; Park JE; Yang JE; Elsherbeny MH; Paik S; Oh KS; Lee BH; Lee MY; Shin KJ; Pae AN; Lee KT; Roh EJ
Bioorg Chem; 2019 Nov; 92():103261. PubMed ID: 31542718
[TBL] [Abstract][Full Text] [Related]
6. Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it.
Sun HP; Zhu J; Chen FH; Zhang SL; Zhang Y; You QD
Eur J Med Chem; 2011 Sep; 46(9):3942-52. PubMed ID: 21708416
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.
Elkamhawy A; Kim NY; Hassan AHE; Park JE; Yang JE; Oh KS; Lee BH; Lee MY; Shin KJ; Lee KT; Hur W; Roh EJ
Eur J Med Chem; 2018 Sep; 157():691-704. PubMed ID: 30130718
[TBL] [Abstract][Full Text] [Related]
8. IKKβ inhibitor identification: a multi-filter driven novel scaffold.
Nagarajan S; Choo H; Cho YS; Shin KJ; Oh KS; Lee BH; Pae AN
BMC Bioinformatics; 2010 Oct; 11 Suppl 7(Suppl 7):S15. PubMed ID: 21106122
[TBL] [Abstract][Full Text] [Related]
9. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
[TBL] [Abstract][Full Text] [Related]
10. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking.
Wang JL; Li L; Hu MB; Wu B; Fan WX; Peng W; Wei DN; Wu CJ
Comput Biol Chem; 2019 Feb; 78():297-305. PubMed ID: 30605855
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases.
Johannes JW; Chuaqui C; Cowen S; Devereaux E; Gingipalli L; Molina A; Wang T; Whitston D; Wu X; Zhang HJ; Zinda M
Bioorg Med Chem Lett; 2014 Feb; 24(4):1138-43. PubMed ID: 24462666
[TBL] [Abstract][Full Text] [Related]
12. New IKK inhibitors: Synthesis of new imidazo[1,2-a]quinoxaline derivatives using microwave assistance and biological evaluation as IKK inhibitors.
Moarbess G; Guichou JF; Paniagua-Gayraud S; Chouchou A; Marcadet O; Leroy F; Ruédas R; Cuq P; Deleuze-Masquéfa C; Bonnet PA
Eur J Med Chem; 2016 Jun; 115():268-74. PubMed ID: 27017554
[TBL] [Abstract][Full Text] [Related]
13. IKK biology.
Liu F; Xia Y; Parker AS; Verma IM
Immunol Rev; 2012 Mar; 246(1):239-53. PubMed ID: 22435559
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).
Christopher JA; Bamborough P; Alder C; Campbell A; Cutler GJ; Down K; Hamadi AM; Jolly AM; Kerns JK; Lucas FS; Mellor GW; Miller DD; Morse MA; Pancholi KD; Rumsey W; Solanke YE; Williamson R
J Med Chem; 2009 May; 52(9):3098-102. PubMed ID: 19348415
[TBL] [Abstract][Full Text] [Related]
15. Identification of human IKK-2 inhibitors of natural origin (Part II): in Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity.
Sala E; Guasch L; Iwaszkiewicz J; Mulero M; Salvadó MJ; Bladé C; Ceballos M; Valls C; Zoete V; Grosdidier A; Garcia-Vallvé S; Michielin O; Pujadas G
Eur J Med Chem; 2011 Dec; 46(12):6098-103. PubMed ID: 22000921
[TBL] [Abstract][Full Text] [Related]
16. Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation.
Sommers CD; Thompson JM; Guzova JA; Bonar SL; Rader RK; Mathialagan S; Venkatraman N; Holway VW; Kahn LE; Hu G; Garner DS; Huang HC; Chiang PC; Schindler JF; Hu Y; Meyer DM; Kishore NN
J Pharmacol Exp Ther; 2009 Aug; 330(2):377-88. PubMed ID: 19478133
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.
Elkamhawy A; Kim NY; Hassan AHE; Park JE; Paik S; Yang JE; Oh KS; Lee BH; Lee MY; Shin KJ; Pae AN; Lee KT; Roh EJ
Eur J Med Chem; 2020 Feb; 188():111955. PubMed ID: 31893550
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
19. Hit identification of IKKβ natural product inhibitor.
Leung CH; Chan DS; Li YW; Fong WF; Ma DL
BMC Pharmacol Toxicol; 2013 Jan; 14():3. PubMed ID: 23294515
[TBL] [Abstract][Full Text] [Related]
20. Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation.
Mitsuhashi S; Shima H; Li Y; Tanuma N; Okamoto T; Kikuchi K; Ubukata M
Int J Oncol; 2008 Nov; 33(5):1027-35. PubMed ID: 18949366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
